0001950047-23-003872.txt : 20230911 0001950047-23-003872.hdr.sgml : 20230911 20230911160949 ACCESSION NUMBER: 0001950047-23-003872 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230911 DATE AS OF CHANGE: 20230911 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001725160 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823607803 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39263 FILM NUMBER: 231247824 BUSINESS ADDRESS: STREET 1: 1359 BROADWAY, SUITE 801 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (212) 433-3791 MAIL ADDRESS: STREET 1: 1359 BROADWAY, SUITE 801 CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Zentalis Pharmaceuticals, LLC DATE OF NAME CHANGE: 20200107 FORMER COMPANY: FORMER CONFORMED NAME: Zeno Pharma, LLC DATE OF NAME CHANGE: 20171212 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Skvarka Jan CENTRAL INDEX KEY: 0001838042 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O TRILLIUM THERAPEUTICS INC. STREET 2: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 144 1 primary_doc.xml 144 0001838042 XXXXXXXX LIVE 0001725160 ZENTALIS PHARMACEUTICALS INC 001-39263 1359 Broadway, Suite 801 New York NY 10018 2124333791 JAN SKVARKA Director COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

5000 126400.00 70609407 09/11/2023 NASDAQ Common 09/09/2023 Restricted Stock Units Issuer N 5000 09/09/2023 N/A Y 09/11/2023 11/18/2022 /s/ Jan Skvarka